Revolutionizing FIP Treatment Accessibility

This chapter explores the significant evolution in the availability of GS 441524, a crucial drug for cats with FIP, highlighting its transition from a risky supply system to being accessible in U.S. pharmacies. The discussion also reflects on the initial challenges faced and sets the stage for future insights on this important treatment.